Literature DB >> 22589609

An overview of bone cells and their regulating factors of differentiation.

Alizae Marny Mohamed1.   

Abstract

Bone is a specialised connective tissue and together with cartilage forms the strong and rigid endoskeleton. These tissues serve three main functions: scaffold for muscle attachment for locomotion, protection for vital organs and soft tissues and reservoir of ions for the entire organism especially calcium and phosphate. One of the most unique and important properties of bone is its ability to constantly undergo remodelling even after growth and modelling of the skeleton have been completed. Remodelling processes enable the bone to respond and adapt to changing functional situations. Bone is composed of various types of cells and collagenous extracellular organic matrix, which is predominantly type I collagen (85-95%) called osteoid that becomes mineralised by the deposition of calcium hydroxyapatite. The non-collagenous constituents are composed of proteins and proteoglycans, which are specific to bone and the dental hard connective tissues. Maintenance of appropriate bone mass depends upon the precise balance of bone formation and bone resorption which is facilitated by the ability of osteoblastic cells to regulate the rate of both differentiation and activity of osteoclasts as well as to form new bone. An overview of genetics and molecular mechanisms that involved in the differentiation of osteoblast and osteoclast is discussed.

Entities:  

Keywords:  Bone cells; osteoblasts; osteoclasts; regulations

Year:  2008        PMID: 22589609      PMCID: PMC3341892     

Source DB:  PubMed          Journal:  Malays J Med Sci        ISSN: 1394-195X


  58 in total

1.  Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.

Authors:  Leonard Rifas; Sophia Arackal; M Neale Weitzmann
Journal:  J Cell Biochem       Date:  2003-03-01       Impact factor: 4.429

2.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

3.  Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts.

Authors:  T Komori; H Yagi; S Nomura; A Yamaguchi; K Sasaki; K Deguchi; Y Shimizu; R T Bronson; Y H Gao; M Inada; M Sato; R Okamoto; Y Kitamura; S Yoshiki; T Kishimoto
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

4.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

5.  Osteocytic expression of mRNA for c-fos and IGF-I: an immediate early gene response to an osteogenic stimulus.

Authors:  J M Lean; A G Mackay; J W Chow; T J Chambers
Journal:  Am J Physiol       Date:  1996-06

6.  The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2.

Authors:  T Katagiri; A Yamaguchi; T Ikeda; S Yoshiki; J M Wozney; V Rosen; E A Wang; H Tanaka; S Omura; T Suda
Journal:  Biochem Biophys Res Commun       Date:  1990-10-15       Impact factor: 3.575

7.  Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse.

Authors:  S C Marks; P W Lane
Journal:  J Hered       Date:  1976 Jan-Feb       Impact factor: 2.645

8.  Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1.

Authors:  J T Thomas; M W Kilpatrick; K Lin; L Erlacher; P Lembessis; T Costa; P Tsipouras; F P Luyten
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

9.  Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.

Authors:  A Mizuno; N Amizuka; K Irie; A Murakami; N Fujise; T Kanno; Y Sato; N Nakagawa; H Yasuda; S Mochizuki; T Gomibuchi; K Yano; N Shima; N Washida; E Tsuda; T Morinaga; K Higashio; H Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

10.  TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor.

Authors:  B R Wong; R Josien; S Y Lee; B Sauter; H L Li; R M Steinman; Y Choi
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

View more
  13 in total

1.  Non-invasive in situ monitoring of bone scaffold activity by speckle pattern analysis.

Authors:  Vahideh Farzam Rad; Majid Panahi; Ramin Jamali; Ahmad Darudi; Ali-Reza Moradi
Journal:  Biomed Opt Express       Date:  2020-10-14       Impact factor: 3.732

Review 2.  Biomaterials via peptide assembly: Design, characterization, and application in tissue engineering.

Authors:  Vincent P Gray; Connor D Amelung; Israt Jahan Duti; Emma G Laudermilch; Rachel A Letteri; Kyle J Lampe
Journal:  Acta Biomater       Date:  2021-10-25       Impact factor: 8.947

3.  Hydrothermally treated titanium surfaces for enhanced osteogenic differentiation of adipose derived stem cells.

Authors:  Vignesh K Manivasagam; Ketul C Popat
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-07-14

Review 4.  Industry 5.0 in Orthopaedics.

Authors:  Madhan Jeyaraman; Arulkumar Nallakumarasamy; Naveen Jeyaraman
Journal:  Indian J Orthop       Date:  2022-08-23       Impact factor: 1.033

Review 5.  Peptide-Modified Biopolymers for Biomedical Applications.

Authors:  Jessica Hersh; David Broyles; José Manuel Condor Capcha; Emre Dikici; Lina A Shehadeh; Sylvia Daunert; Sapna Deo
Journal:  ACS Appl Bio Mater       Date:  2020-12-24

Review 6.  Mesenchymal stem cells: amazing remedies for bone and cartilage defects.

Authors:  Parisa Kangari; Tahereh Talaei-Khozani; Iman Razeghian-Jahromi; Mahboobeh Razmkhah
Journal:  Stem Cell Res Ther       Date:  2020-11-23       Impact factor: 6.832

Review 7.  Regulation of the mesenchymal stem cell fate by interleukin-17: Implications in osteogenic differentiation.

Authors:  Jelena Krstić; Slavko Mojsilović; Sonja S Mojsilović; Juan F Santibanez
Journal:  World J Stem Cells       Date:  2021-11-26       Impact factor: 5.326

8.  Long Chain Omega-3 Polyunsaturated Fatty Acid Supplementation Protects Against Adriamycin and Cyclophosphamide Chemotherapy-Induced Bone Marrow Damage in Female Rats.

Authors:  Chia-Ming Fan; Yu-Wen Su; Peter R Howe; Cory J Xian
Journal:  Int J Mol Sci       Date:  2018-02-06       Impact factor: 5.923

Review 9.  Natural and Synthetic Polymers for Bone Scaffolds Optimization.

Authors:  Francesca Donnaloja; Emanuela Jacchetti; Monica Soncini; Manuela T Raimondi
Journal:  Polymers (Basel)       Date:  2020-04-14       Impact factor: 4.329

Review 10.  Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies.

Authors:  Richa Rathore; Brian A Van Tine
Journal:  J Clin Med       Date:  2021-03-12       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.